When was Helix founded?

Helix was founded in 2015 and raised its 1st funding round 2 years after it was founded.

Where is Helix located?

Helix is headquartered in San Francisco, United States.

Who is the current CEO of Helix?

James Lu of Helix. They have also founded 1 company.

How many employees does Helix have?

As of Mar 31, 2026, the latest employee count at Helix is 585.

Is Helix a funded company?

Helix is a funded company, having raised a total of $435M across 4 funding rounds to date. The company's 1st funding round was a $***** Series D round, raised on Apr 28, 2017.

When was the latest funding round of Helix?

Helix's latest funding was a $***** Series E round on Jun 03, 2021, with participation from 5 investors.

Where does Helix rank among its competitors?

Helix ranks 2nd amongst 255 active competitors, of which 43 are funded. It stands 1st in terms of total funding among its competitors. The most recent competitor to raise funding was Genialis, which secured $700K in Dec, 2025.

Who are the top competitors of Helix?

Helix's top competitors include Benchling, NTxBio and Recludix Pharma. Among them, Genialis secured the most recent funding round in December, 2025.

Helix - 2026 Company Profile, Team, Funding & Competitors

Helix is a series E company based in San Francisco (United States), founded in 2015 by Justin Kao, James Lu and Scott Burke. It operates as a Provider of a genomic database for clinical research. Helix has raised $435M in funding from investors like DFJ Growth, Warburg Pincus and Kleiner Perkins. The company has 255 active competitors, including 43 funded and 28 that have exited. Its top competitors include companies like Benchling, NTxBio and Recludix Pharma.

Company Details

Provider of a genomic database for clinical research. The company has a proprietary clinical-genomic database of Exome+ sequencing data and deep phenotypic data that can be used to accelerate the drug development lifecycle from discovery to commercialization. It offers data analytics platforms for health systems, life sciences companies, payers, and government partners to accelerate the integration of genomic data into patient care and public health decision-making.

Website: www.helix.com/
Social

Key Metrics

Founded Year

2015

Location

San Francisco, United States

Stage

Series E

Total Funding

$435M in 4 rounds

Latest Funding Round

Series E, Jun 03, 2021, $*****

Investors

DFJ Growth & 13 more

Ranked

2^nd among 255 active competitors

Employee Count

585 as on Mar 31, 2026

Similar Companies

MyHeritage & 804 more

View Helix's full profile

Helix has raised a total funding of $435M over 4 rounds. Its first funding round was on Apr 28, 2017. Its latest funding round was a Series E round on Jun 03, 2021 for $*****. 5 investors participated in its latest round. Helix has 14 institutional investors.

Here is the list of recent funding rounds of Helix:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jun 03, 2021	9273635	Series E	6554182	2306532	6416356	7391338
Jul 31, 2020	3134553	Grant (prize money)	1050360	9722115	9992869	NIH
Mar 01, 2018	1227852	Series E	9462210	2035396	DFJ Growth	Illumina & 4 more

Access funding benchmarks and valuations. Sign up today!

View details of Helix's funding rounds and investors

The founders of Helix are Justin Kao, James Lu and Scott Burke. James Lu is the CEO of Helix.

Here are the details of Helix's key team members:

Justin Kao: Former Co-Founder of Helix. They serve on the board of 1 company.
Contact Info: 2 email addresses
James Lu: CEO, Co-Founder, Board Member of Helix.
Scott Burke: Former Co-Founder of Helix.

View details of Helix's Founder profiles and Board Members

Helix's employee count trend

Helix has 585 employees as of Mar 26. Here is Helix's employee count trend over the years:

Uncover Helix's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Helix include Benchling, NTxBio and Recludix Pharma. Here is the list of Top 10 competitors of Helix, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Benchling 2012, San Francisco (United States), Series F	Provider of a cloud-based bioinformatics platform for biotech research	$412M	Altimeter Capital, Benchmark & 28 others	73/100
2nd	Helix 2015, San Francisco (United States), Series E	Provider of a genomic database for clinical research	$435M	Kleiner Perkins, DFJ Growth & 12 others	71/100
3rd	NTxBio 2016, Santa Fe (United States), Series B	Provider of bio informatics platform to develops biologics and therapeutics	$85.1M	RA Capital Management, Anzu Partners & 5 others	61/100
4th	Recludix Pharma 2020, San Diego (United States), Series A	Provider of the online platform for drug discovery and development	$60M	Access Industries, New Enterprise Associates ... & 1 others	60/100
5th	Immuneering Corporation 2019, Cambridge (United States), Public	Provider of an AI-enabled bioinformatics platform for clinical solutions	$79M	Citadel, BlackRock & 5 others	60/100
6th	Latch 2021, San Francisco (United States), Series A	Provider of a web-based platform for genomic bioinformatics	$33M	Lux Capital, Coatue & 7 others	58/100
7th	BostonGene 2015, Waltham (United States), Series B	Developer of cloud-based information and analytics platform to treat cancer	$200M	NEC, Japan Industrial Partners & 1 others	57/100
8th	Genialis 2015, Boston (United States), Series A	Developer of end-to-end bioinformatics software solutions	$16M	Debiopharm, Redalpine & 9 others	56/100
9th	Genomind 2009, King Of Prussia (United States), Series C	Developer of genetic tests for personalised medicines to enhance mental health treatment	$64.4M	Claritas Capital, SVB & 1 others	56/100
10th	NextBio 2004, Santa Clara (United States), Acqui-Hired	NextBio provides a platform to aggregate and interpret large quantities of genomic data for research and clinical applications.	$28.3M	Rising Tide Fund, RONA Holdings & 6 others	55/100